Rainbow CR Tablet (Levodropropizine)

Adult dose

Adults: Take 1 tablet per dose (equivalent to 90mg of levodropropizine) orally 2 times daily. This medicine is an extended-release formulation; swallow it whole without splitting or crushing it.

This medicine should not be used by certain patients. For example, those with allergies to this medicine or its ingredients, those with excessive bronchial mucus secretion, and those with ciliary dysfunction should not take this medicine. In addition, women who are pregnant or may become pregnant and those who are nursing should not use this medicine. Patients with severe liver disease should also avoid this medicine. This medicine contains lactose, so those with lactose intolerance or related genetic disorders should avoid it. There are also cases where this medication should be used with caution. Persons with severe heart failure or severe kidney function decline, elderly patients, and children should take care when using this medication. There may be side effects when taking this medicine. Gastrointestinal symptoms such as nausea, dyspepsia, and constipation may rarely occur, while central nervous system effects such as drowsiness, headache, and dizziness may occur frequently or rarely. Symptoms such as dizziness in the ears or eyelid swelling have also been reported. Blood tests may show increased leukocytes in the urine or elevated liver function values. Care should be taken when driving or operating machinery, as this medicine can cause drowsiness, especially if taken with alcohol, which may exacerbate drowsiness. This is a sustained-release dosage form, and it is advisable to use a different formulation that can be divided for children. Care is needed when taken with sedatives, as excessive sedation effects may occur. Women who are pregnant or breastfeeding should not take this medicine. When storing, keep it in a safe place out of reach of children, and avoid transferring the medicine to another container, as it can lead to a decrease in quality or cause accidents.

• Nausea
• dyspepsia
• constipation
• drowsiness
• headache
• dizziness
• postural vertigo
• eyelid swelling
• increased urinary leukocytes
• elevated ALT

This medicine should be stored in a sealed container to protect it from air and moisture. Additionally, it is important to maintain a room temperature between 1 and 30 degrees Celsius when storing the medicine. Proper storage will ensure the safety of the medicine's efficacy.

Appearance

Biconvex sustained-release tablet, composed of a white to light yellow upper layer and a white lower layer.

Package unit

30 tablets/bottle, 300 tablets/bottle